Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites
about
Description of a nanobody-based competitive immunoassay to detect tsetse fly exposureSalivary Biomarkers in the Control of Mosquito-Borne DiseasesHuman antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector controlHuman antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, AngolaIdentification of salivary gland proteins depleted after blood feeding in the malaria vector Anopheles campestris-like mosquitoes (Diptera: Culicidae).Characterization of guinea pig antibody responses to salivary proteins of Triatoma infestans for the development of a triatomine exposure markerSerological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu.Serological responses and biomarker evaluation in mice and pigs exposed to tsetse fly bites.Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors.First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts.Evaluation of the human IgG antibody response to Aedes albopictus saliva as a new specific biomarker of exposure to vector bites.An insight into the sialome of blood-feeding Nematocera.IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.Anopheles salivary gland proteomes from major malaria vectors.Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectorsAnopheles gambiae salivary protein expression modulated by wild Plasmodium falciparum infection: highlighting of new antigenic peptides as candidates of An. gambiae bites.Implication of haematophagous arthropod salivary proteins in host-vector interactionsMembers of the salivary gland surface protein (SGS) family are major immunogenic components of mosquito saliva.Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites.Anopheline salivary protein genes and gene families: an evolutionary overview after the whole genome sequence of sixteen Anopheles species.Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.Assessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bitesgSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas.Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker.Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal.Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A HypothesisInsights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and LeishmaniaOperational Assessment of Long-Lasting Insecticidal Nets by Using an Anopheles Salivary Biomarker of Human-Vector Contact.Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border.Human antibody response to Aedes albopictus salivary proteins: a potential biomarker to evaluate the efficacy of vector control in an area of Chikungunya and Dengue Virus transmission.First screening of Aedes albopictus immunogenic salivary proteins.Detection of immunogenic proteins from Anopheles sundaicus salivary glands in the human serum.Immunological consequences of arthropod vector-derived salivary factors.Differential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites.Uneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.
P2860
Q27304633-5D4A5674-9520-4DBB-81A8-9A7BE01D9873Q28085738-87659369-EAA4-4F7F-9410-26517986B7ECQ28744241-8B403C74-4B0F-4961-89A1-42392F681F61Q31101514-B90C9EB0-656C-4D80-9FEF-31C4E0263430Q31153347-DF06CDB5-C94B-4200-B361-3C94EA0B56CCQ31156116-A91C58F6-7C95-4295-AAB2-908EFA744445Q33604400-F22609BE-4B49-4979-9EE3-0CFD338E07B6Q33650544-E5E31E1A-3433-4E62-AA26-E9B2237EB041Q33855766-90A66150-CD78-4351-95F4-D9CA57C1C041Q34023538-0C9D3EAB-8F7E-4953-99EA-2535124C2433Q34110724-75F9AA74-337C-4C5D-90E4-E3D9E116739CQ34171748-A56FD759-9FBA-4B8D-B58E-22D2A0FDDFF2Q34176558-EF8B5D79-1F88-4ACE-BA30-20E85F7BFE5EQ34328747-8D558EF5-C50B-4830-8973-5B14DD7270B3Q34351117-91745D41-76F6-48A4-BFD5-631B594D7691Q34475692-5322603C-BF75-4AAF-9B67-83694A909FE3Q34620299-68448DDF-BFF3-49D0-A186-4350238200A9Q34875709-97C60946-C724-4B1F-88BD-35684B0E3FB4Q35398192-0130EF33-D75E-47CC-AAA6-789E678838DDQ35562509-B771BF84-8CFF-4419-B807-0FA8D4C82C65Q35880068-20ECE365-A06E-4292-A3E1-7A3D7485B50CQ35916023-4B821D47-A4C4-4E56-8789-761595E8499DQ36160018-17D35AD0-63BD-4C1A-AC5E-B2D81C7859C6Q36213292-D579930A-A45A-41EF-826E-2E9F793D4368Q36279030-41FB066C-8803-4864-ACD4-13782445C551Q36521143-198B65F7-BE23-4215-8F10-278D66B3F96AQ36541673-ACAC87D9-3F77-4428-9271-AA57E693A39CQ36780477-1700DDF4-A569-4755-A54F-41B4535E8AB7Q36945208-87E42FA4-C4AA-4050-934A-EDF4DA6F5E8EQ37153769-03D19595-939B-4E7C-BE7B-1A537C1B9749Q37293213-BC945437-6169-4B88-82C3-170C9FF21301Q38680919-6614E881-1824-48ED-B10B-AE59B014AE22Q39121517-B72A9A3A-783C-4329-8DEF-539E1DE0127CQ39609570-0DD187C6-33C2-4CED-8153-903A35BA84BAQ40190852-BD55DB4E-69AA-4146-9C60-9FD334EA7134Q42992616-AE17F16A-AACD-43C5-AE1F-82B19482F47BQ44151685-905BD7FC-9B6B-4E04-8E60-092DFFB22F11Q44161140-FD7989CE-D867-48CE-9583-A070CEB0BF18Q44164631-A7457423-F2AC-4025-AF8E-D595A0969856Q55079599-76EDD4C5-DBEE-48CE-819D-C7C6BA91DDFE
P2860
Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Human IgG response to a saliva ...... el exposure to Anopheles bites
@ast
Human IgG response to a saliva ...... el exposure to Anopheles bites
@en
Human IgG response to a saliva ...... el exposure to Anopheles bites
@nl
type
label
Human IgG response to a saliva ...... el exposure to Anopheles bites
@ast
Human IgG response to a saliva ...... el exposure to Anopheles bites
@en
Human IgG response to a saliva ...... el exposure to Anopheles bites
@nl
prefLabel
Human IgG response to a saliva ...... el exposure to Anopheles bites
@ast
Human IgG response to a saliva ...... el exposure to Anopheles bites
@en
Human IgG response to a saliva ...... el exposure to Anopheles bites
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Human IgG response to a saliva ...... el exposure to Anopheles bites
@en
P2093
Badara Cisse
Cheikh Sow
Denis Boulanger
Franck Remoue
Marie Rossignol
Sylvie Cornelie
P2860
P2888
P3181
P356
10.1186/1475-2875-8-198
P577
2009-08-13T00:00:00Z
P5875
P6179
1008261481